This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Roche Diagnostics Operations, Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Thomas Mock - Innovator in Immunoassay Technology
Introduction
Thomas Mock is a notable inventor based in Gauting, Germany. He has made significant contributions to the field of immunoassays, particularly in reducing interferences that can affect the accuracy of test results. His innovative approach has the potential to enhance the reliability of various diagnostic applications.
Latest Patents
Thomas Mock holds a patent for a method that determines an analyte in a sample. This method involves contacting the sample with at least a first and a second detector compound. The process includes determining the amount of complexes formed by the detector compounds and using this information to ascertain the analyte's presence. The first and second detector compounds are designed with non-identical labels, which helps in minimizing interferences during the detection process.
Career Highlights
Thomas Mock is currently employed at Roche Diagnostics Operations, Inc., a leading company in the field of medical diagnostics. His work focuses on developing advanced methods and kits for detecting analytes in various samples. His contributions have been instrumental in improving diagnostic accuracy and efficiency.
Collaborations
Throughout his career, Thomas has collaborated with esteemed colleagues such as Johannes Polz and Barbara Upmeier. These collaborations have fostered a productive environment for innovation and have led to advancements in immunoassay technologies.
Conclusion
Thomas Mock's work in immunoassay technology exemplifies the impact of innovative thinking in the medical diagnostics field. His patent and collaborations highlight his commitment to enhancing diagnostic methods, ultimately benefiting healthcare practices.